Pesquisas alternativas:
company sars » company cars (Expandir a Pesquisa), company car (Expandir a Pesquisa), company sues (Expandir a Pesquisa)
lncd company » lnc company (Expandir a Pesquisa)
complex can » complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa), complex cell (Expandir a Pesquisa)
sars how » stars how (Expandir a Pesquisa), wars how (Expandir a Pesquisa), cars how (Expandir a Pesquisa)
l compr » l comper (Expandir a Pesquisa), la compr (Expandir a Pesquisa), l comps (Expandir a Pesquisa)
compr a » ompr a (Expandir a Pesquisa), campr a (Expandir a Pesquisa)
a newly » _ newly (Expandir a Pesquisa)
can now » can non (Expandir a Pesquisa), can new (Expandir a Pesquisa), can ngoc (Expandir a Pesquisa)
5 par » 5 para (Expandir a Pesquisa), 5 part (Expandir a Pesquisa), _ par (Expandir a Pesquisa)
company sars » company cars (Expandir a Pesquisa), company car (Expandir a Pesquisa), company sues (Expandir a Pesquisa)
lncd company » lnc company (Expandir a Pesquisa)
complex can » complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa), complex cell (Expandir a Pesquisa)
sars how » stars how (Expandir a Pesquisa), wars how (Expandir a Pesquisa), cars how (Expandir a Pesquisa)
l compr » l comper (Expandir a Pesquisa), la compr (Expandir a Pesquisa), l comps (Expandir a Pesquisa)
compr a » ompr a (Expandir a Pesquisa), campr a (Expandir a Pesquisa)
a newly » _ newly (Expandir a Pesquisa)
can now » can non (Expandir a Pesquisa), can new (Expandir a Pesquisa), can ngoc (Expandir a Pesquisa)
5 par » 5 para (Expandir a Pesquisa), 5 part (Expandir a Pesquisa), _ par (Expandir a Pesquisa)
1
Por Salsman, John M., Yanez, Betina, Smith, Kristin N., Beaumont, Jennifer L., Snyder, Mallory A., Barnes, Khouri, Clayman, Marla L.
Publicado no J Natl Compr Canc Netw (2016)
“... types (60%–74% informed). There was a significant effect for patient gender (OR=3.57, CI: 1.33, 9.60, p...”Publicado no J Natl Compr Canc Netw (2016)
Obter o texto integral
Obter o texto integral
Artigo
2
Por Madsen, Lydia T., Kuban, Deborah A., Choi, Seungtaek, Davis, John W., Kim, Jeri, Lee, Andrew K., Domain, Delora, Levy, Larry, Pisters, Louis L., Pettaway, Curtis A., Ward, John F., Logothetis, Christopher, Hoffman, Karen E.
Publicado no J Natl Compr Canc Netw (2014)
“...PURPOSE: Clinical oncology trials are hampered by low accrual rates with less than 5% of adult...”Publicado no J Natl Compr Canc Netw (2014)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Hoppe, Richard T., Advani, Ranjana H., Ai, Weiyun Z., Ambinder, Richard F., Aoun, Patricia, Bello, Celeste M., Benitez, Cecil M., Bierman, Philip J., Blum, Kristie A., Chen, Robert, Dabaja, Bouthaina, Forero, Andres, Gordon, Leo I., Hernandez-Ilizaliturri, Francisco J., Hochberg, Ephraim P., Huang, Jiayi, Johnston, Patrick B., Khan, Nadia, Maloney, David G., Mauch, Peter M., Metzger, Monika, Moore, Joseph O., Morgan, David, Moskowitz, Craig H., Mulroney, Carolyn, Poppe, Matthew, Rabinovitch, Rachel, Seropian, Stuart, Tsien, Christina, Winter, Jane N., Yahalom, Joachim, Burns, Jennifer L., Sundar, Hema
Publicado no J Natl Compr Canc Netw (2015)
“... therapy, followed by restaging with PET/CT to assess treatment response using the Deauville criteria (5...”Publicado no J Natl Compr Canc Netw (2015)
Obter o texto integral
Obter o texto integral
Artigo
4
Por Liu, Yuchuan, Pixley, Robin, Fusaro, Mario, Godoy, Gustavo, Kim, Erin, Bromberg, Michael E., Colman, Robert W.
Publicado em 2009
“... and D5 inhibit migration and invasion of human prostate cancer cells via a EGFR/uPAR pathway, suggesting...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Pronk, Sander, Páll, Szilárd, Schulz, Roland, Larsson, Per, Bjelkmar, Pär, Apostolov, Rossen, Shirts, Michael R., Smith, Jeremy C., Kasson, Peter M., van der Spoel, David, Hess, Berk, Lindahl, Erik
Publicado em 2013
“... of ligands. At the same time, advances in performance and scaling now make it possible to model complex...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Eve Laplante
Publicado em 2015-11-01
“... saine, certes, mais jusqu’à une certaine limite. Cette limite se trace par ailleurs au moment où l...”Publicado em 2015-11-01
Obter o texto integral
Artigo
7
Publicado no Mol Cell Proteomics
(2019)
“... and we are just now in a situation where we can get high selectivity (<4 m/z) across a majority...”Obter o texto integral
Artigo
8
Por Little, PJ, Hollenberg, MD, Kamato, D, Thomas, W, Chen, J, Wang, T, Zheng, W, Osman, N
Publicado no Br J Pharmacol (2016)
“...’. Complicating issues further, we now know that activating one receptor can rapidly trigger the local release...”Publicado no Br J Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... devised to manage these challenging cases, including the combination of endocapsular or pars plana...”
Obter o texto integral
Obter o texto integral
Artigo
10
“... devised to manage these challenging cases, including the combination of endocapsular or pars plana...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Shen, Wei-Bin, McDowell, Kimberly A., Siebert, Aubrey A., Clark, Sarah M., Dugger, Natalie V., Valentino, Kimberly M., Jinnah, H. A., Sztalryd, Carole, Fishman, Paul S., Shaw, Christopher A., Jafri, M. Samir, Yarowsky, Paul J.
Publicado em 2010
“...OBJECTIVE: Exposure to a number of drugs, chemicals or environmental factors can cause parkinsonism...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo